Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Recalled Crecelac Formula May Carry Cronobacter Contamination Risk, FDA Warns Warning comes after FDA took intense criticism for not responding quickly enough to a similar problem with cronobacter in Similac infant formula in 2022, which sickened babies nationwide June 5, 2024 Grace Muller Add Your Comments Federal food safety officials indicate that recent testing of recalled Crecelac infant formula suggests that the products may carry a risk of potentially dangerous cronobacter infections for babies, which is the same bacteria that caused severe illnesses among infants fed Similac formula several years ago. The U.S Food and Drug Administration (FDA) issued a Crecelac cronobacter safety alert on June 3, expanding a recently announced recall of the infant formula products after a sample from a retail store in Texas tested positive for cronobacter on May 29. Cronobacter is a bacterium that can lead to bloodstream infections like sepsis and central nervous system infections like meningitis. In infants, complications from a cronobacter infection can include brain abscesses, developmental delays, motor impairments, and even death. Symptoms of cronobacter infection in infants may include poor feeding, irritability, temperature fluctuations, jaundice, grunting breaths, and abnormal body movements. In 2022, cronobacter was found in recalled Similac infant formula, which was linked to dozens of reports involving severe illnesses and baby formula lawsuits filed by families throughout the U.S. BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION This new warning follows a Crecelac infant formula recall initially issued on May 25, along with other infant formula products imported and distributed by Dairy Manufacturers Inc., due to the products failing to comply with the FDA’s infant formula regulations. The formula was sold in the U.S illegally because the manufacturer failed to submit the required premarket notification to the FDA. The recall included Crecelac 12.4 oz containers sold in cardboard and aluminum cans, which were were mainly distributed in March, April, and May of 2024 through retail stores in Texas. However, that recall was expanded to include Crecelac Infant 0-12, with a UPC of 8 50042 40847 6, lot code 24 039 1 CHE 352-1, and an expiration date of August 2025, after a sample tested positive for cronobacter. It can be identified by the batch code on the bottom of the can. Consumers who have purchased Crecelac Infant 0-12 should stop using the recalled product and return it to the place of purchase for a full refund, the FDA warns. Those who have concerns about an injury or illness should contact a healthcare provider. Consumers with questions can reach the company at 1-972-347-2341, Monday to Friday, from 9:30 a.m. to 5 p.m. EST. 2024 Similac Recall Lawsuit Update The recall comes as the FDA has taken a closer look at the risks of infant formula contamination after similar problems led to a major Similac recall in 2022, when it was revealed that the powdered infant formula had been widely distributed with cronobacter and salmonella bacteria. The FDA faced sharp criticism over the following months, when it was discovered that the manufacturer had been aware of the contamination issues for months before the recall was announced, but was able to continue distributing the products. More than 80 Similac food poisoning lawsuits have been filed by parents of children diagnosed with various injuries after consuming the recalled infant formula, alleging that Abbott Laboratories neglected safety standards for profit. Given common allegations raised in complaints being pursued throughout the federal court system, all lawsuits over the Similac recall have been centralized before U.S. District Judge Matthew F. Kennelly in the Northern District of Illinois for coordinated discovery and pretrial proceedings. To help the parties evaluate the strengths and weaknesses of claims, Judge Kennelly has established a Similac lawsuit bellwether trial process, where the parties are focusing on preparing a small number of representative claims to go before juries. While the outcome of these bellwether trials will not be binding on other cases, they will likely have a big impact on the average Similac recall settlement amounts the manufacturer may have to pay to avoid dozens of individual claims being set for trial in the coming years. Tags: Cronobactor, Infant Formula Recall, Similac Recall Find Out If You Qualify for Infant Formula NEC Compensation More Baby Formula Lawsuit Stories Second NEC Baby Formula Bellwether Trial Will Not Move Forward July 29, 2025 Similac NEC Settlement Talks Result in MDL Census Order for Filed and Unfiled Claims July 24, 2025 Mead Johnson Must Face Enfamil NEC Lawsuit in Missouri State Court July 8, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: today) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: yesterday) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025) Student Social Media Addiction Lawsuits Brought by School Districts Will Be First MDL Bellwether Trials (Posted: 2 days ago) Claims that allege social media platforms are intentionally designed to cause addiction in students will be the first federal lawsuits to go before juries. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITRoblox Kidnapping Lawsuit Filed After Child Was Abducted and Sex Trafficked (09/03/2025)ChatGPT Wrongful Death Lawsuit Claims AI Helped Teen Commit Suicide (08/28/2025)TikTok’s Addictive Algorithms Prey on Teens, Contributing to Student Mental Health Issues: Lawsuit (08/26/2025)
Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: today) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: yesterday) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)
Student Social Media Addiction Lawsuits Brought by School Districts Will Be First MDL Bellwether Trials (Posted: 2 days ago) Claims that allege social media platforms are intentionally designed to cause addiction in students will be the first federal lawsuits to go before juries. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITRoblox Kidnapping Lawsuit Filed After Child Was Abducted and Sex Trafficked (09/03/2025)ChatGPT Wrongful Death Lawsuit Claims AI Helped Teen Commit Suicide (08/28/2025)TikTok’s Addictive Algorithms Prey on Teens, Contributing to Student Mental Health Issues: Lawsuit (08/26/2025)